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Available online 26 April 2017Disturbances in bone blood ﬂow have been shown to have deleterious effects on bone properties yet there re-
mainmany unanswered questions about skeletal perfusion in health and disease, partially due to the complexity
ofmeasurementmethodologies. The goal of this studywas use ﬂuorescentmicrospheres in rats to assess regional
bone perfusion by adapting mouse-speciﬁc ﬂuorescent microsphere protocol. Ten ﬁfteen-week old Sprague
Dawley rats were injected with ﬂuorescent microspheres either via cardiac injection (n = 5) or via tail vein in-
jection (n= 5). Femora and tibiae were harvested and processed to determine tissue ﬂuorescence density (TFD)
which is proportional to the number of spheres trapped in the tissue capillaries. Right and left total femoral TFD
(2.77± 0.38 and 2.70± 0.24, respectively) and right and left tibial TFD (1.11± 0.26 and 1.08± 0.34, respective-
ly) displayed bilateral symmetry in ﬂowwhen assessed in cardiac injected animals. Partitioning of the bone per-
fusion into three segments along the length of the bone showed the distal femur and proximal tibia received the
greatest amount of perfusion within their respective bones. Tail vein injection resulted in unacceptably low TFD
levels in the tibia from 4 of the 5 animals. In conclusion this report demonstrates the viability of cardiac injection
of ﬂuorescent microspheres to assess bone tissue perfusion in rats.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Animal models1. Introduction
Bone blood ﬂow plays a crucial role in bone growth (Fleming et al.,
2001), fracture repair (Grundnes and Reikerås, 2009; Maes et al.,
2010; Tomlinson and Silva, 2014), and bone homeostasis (Carulli et
al., 2013; McCarthy, 2006). Disturbances to bone blood ﬂow have
been shown to have deleterious effects on bone health and function
(Carulli et al., 2013; Colleran et al., 2000; Prisby et al., 2007; Stabley et
al., 2015, 2013) yet there remain many unanswered questions about
skeletal perfusion in health and disease, partially due to the complexity
of measurement methodologies (McCarthy, 2006).
Radioactive microspheres were long considered the experimental
gold standard for the determination of skeletal perfusion (McCarthy,
2006) due to their accuracy and ease of analysis (Anetzberger et al.,
2004). Upon injection into the animal, microspheres lodge in tissue cap-
illaries in direct proportion to the fraction of cardiac output perfusing
the tissue (McCarthy, 2006). Tissue analysis is relatively straightfor-
ward, even for mineralized tissue, in that once tissues of interest areell Biology, MS 5035, Indiana
lis, IN 46202, United States.
ss article under the CC BY-NC-ND licharvested, blood ﬂow is estimated via a gamma spectrometerwithmin-
imal tissue processing (Colleran et al., 2000; Kirkeby and Berg-Larsen,
1991; Schimmel et al., 2000; Stabley et al., 2013). Various limitations
of radioactive microspheres, including cost, health risks, and the neces-
sity for precautionswith use and disposal (Glenny et al., 1993), have re-
sulted in exploration of alternative methods.
Fluorescent microspheres, which work on the same principal as ra-
dioactive spheres in that they become entrapped within capillaries,
have been shown to allowmeasurement of organ perfusion as effective-
ly as radioactive microspheres (Glenny et al., 1993). Analysis of ﬂuores-
cent microspheres requires degradation and ﬁltration of the tissues of
interest before the samples can be analyzed and has been effectively
used in numerous soft tissue across multiple species (Altemeier et al.,
2000; Anetzberger et al., 2004; De Visscher et al., 2003; Glenny et al.,
1993; Hlastala et al., 1996). Processing of skeletal tissue presents more
challenges for ﬂuorescent microspheres compared to soft tissue, per-
haps helping to explain why ﬂuorescent sphere data exists only for
mice (Serrat, 2009) and rabbits (Anetzberger et al., 2004).
In the present study, we sought to use ﬂuorescent microspheres in
rats to assess regional bone perfusion. The goal was to adapt a ﬂuores-
cent microsphere protocol used in mice (Serrat, 2009) to determine
the variability of skeletal perfusion both within and among a set ofense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
141M.W. Aref et al. / Bone Reports 6 (2017) 140–144normal rats, as well as to test various perturbations in experimental
methodology.
2. Methods
2.1. Microsphere storage and ﬂuorescence decay
In order to determine characteristics of the microspheres, several
perturbations in storage and analyses were carried out prior to animal
experiments. The effect of different methods of storage on ﬂuorescence
quantiﬁcation was examined by placing a known amount of micro-
spheres (50,000 beads in 0.05 mL) in either phosphate buffered saline
(PBS) or ethanol (EtOH). Additional sets of microspheres were placed
in PBS and frozen at−4 °C or−20 °C. Finally, the stability of ﬂuores-
cence over time after being released from the microspheres was mea-
sured over 10 days.
2.2. Animals
Fifteen-week old male Sprague Dawley rats (n = 10) were used for
this study. All procedures were approved by the Indiana University
School of Medicine Animal Care and Use Committee prior to initiating
the study.
2.3. Microsphere injection
Polystyrene, red ﬂuorescent (580/605), 15 μm microspheres
(FluoSpheres, ThermoFisher), were used for blood ﬂow determination.
Microsphere injection in half of the rats (n= 5) was performed as pre-
viously described with minor adaptations for rats (Serrat, 2009). The
process is summarized and illustrated in Fig. 1. Brieﬂy, under isoﬂurane
anesthesia, the chest cavity was opened to allow visualization of the
heart. A 2.5 mL solution of microspheres (containing one million
spheres/mL) was injected in the apex of the left ventricle of the beating
heart. The spheres were allowed to circulate for 60 s before the animal
was euthanized and tissues collected. The number of microspheres
injected was based, on a mg/kg basis, off of using 2 × 105 microspheres
for a 43 gmousewhichworks out to 4.65× 106 spheres/kg;we rounded
up to 5.0 × 106 spheres/kg for ease (Serrat, 2009). A pilot study was
done to verify that the number of spheres entrapped in bone vascula-
ture using a 2.5 million sphere injection was within the generatedFig. 1. Graphical depiction of microsphere protocol including microspstandard curve used to estimatemicrosphere number. Due to thepoten-
tial variability of cardiac function after opening the chest cavity, another
ﬁve rats were administered a similar number of microspheres (2.5 mil-
lion) via a tail vein catheter. For these animals, microspheres were
allowed to circulate for 5 min before the rats were euthanized and tis-
sues collected.
2.4. Sample processing
Femur and tibia sampleswere divided into proximal, middle (diaph-
ysis), and distal segments as previously described (Colleran et al., 2000).
Marrowwas left intact in all bone specimens. Bone sampleswere placed
in individual amber vials with 15mL of Cal-Ex Decalciﬁer solution. After
4 days, decalciﬁed bone samples were placed in 5% ethanolic potassium
hydroxide for degradation. Samples were vortexed every 24 h to ensure
complete degradation. After 96 h of degradation, samples were ﬁltered
through polyamidemesh ﬁlters (5 μmpore size). 1 mL of Cellosolve ac-
etate (2-ethoxyethyl acetate, 98%, Sigma, cat. no. 109967) was added to
each of the ﬁltered samples to break themicrospheres open and expose
the ﬂuorescence.
2.5. Fluorescence quantiﬁcation
All ﬂuorescence measurements were made using the SpectraMax
i3x microplate reader (Molecular Devices, CA). Three 100 μL aliquots
from each sample were placed in a 96-well microplate for ﬂuorescence
quantiﬁcation. Red ﬂuorescence was measured using an excitation of
580 nm and an emission of 620 nm. Standard curves of serial dilutions
with known amounts of microspheres were generated on the day of
analysis. Standard curves generated were used to approximate the
number of spheres in a given sample. All data is presented as tissueﬂuo-
rescence density (TFD) as AU/g and scaled by 106.
2.6. Statistical analysis
All analyses were performed using the Statistics Toolbox in MATLAB
software. Paired student t-tests were utilized to compare right and left
TFD measurements of the femora and tibiae. A priori α-levels were set
at 0.05 to determine signiﬁcance. Coefﬁcients of variation (CV)were cal-
culated within each bone segment (using data from both right and left
limbs; n = 10).here injection, tissue processing and ﬂuorescence quantiﬁcation.
Table 1
Tissue ﬂuorescence density in the femur and tibia following intra-cardiac injection of
microspheres.
Animal Proximal Diaphysis Distal Total
Right Left Right Left Right Left Right Left
Femur
1 2.01 2.17 1.08 1.27 5.02 5.57 2.73 2.80
2 1.78 1.86 2.40 1.40 4.19 4.37 2.77 2.63
3 2.30 2.87 1.64 1.72 4.15 3.75 2.84 2.90
4 3.10 2.50 3.24 2.45 3.51 3.51 3.28 2.83
5 1.73 1.61 1.84 1.78 3.13 3.60 2.22 2.31
Mean 2.18 2.20 2.04 1.72 4.00 4.16 2.77 2.70
Stdev 0.56 0.50 0.82 0.46 0.72 0.86 0.38 0.24
CV 0.23 0.34 0.18 0.11
Tibia
1 2.45 2.51 0.63 0.39 1.40 1.06 1.51 1.37
2 2.25 2.49 0.49 0.59 0.57 0.81 1.13 1.44
3 1.14 1.46 0.60 0.49 0.52 0.46 0.81 0.87
4 2.04 1.14 0.55 0.23 0.52 0.26 1.12 0.63
5 1.45 1.75 0.60 0.71 0.57 0.39 0.96 1.10
Mean 1.87 1.87 0.57 0.48 0.72 0.60 1.11 1.08
Stdev 0.55 0.61 0.06 0.19 0.38 0.33 0.26 0.34
CV 0.29 0.26 0.52 0.26
Tissue ﬂuorescence density (TFD) data presented as AU/g and scaled by 106. CV= coefﬁ-
cient of variation among right and left (combined together so n = 10 specimens per CV)
bone segments across all ﬁve animals.
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Neither storage of intact microspheres in EtOH or freezing tempera-
tures for 24 h altered ﬂuorescence of the spheres compared to recom-
mended storage in PBS (Fig. 2A). Furthermore, measurement of
ﬂuorescence showed no decay after 4 or 10 days relative to measures
taken immediately after ﬂuorescence release (Fig. 2B).
Tissue ﬂuorescence density (TFD) data for the various regions of
femora and tibia from animals administered microspheres through the
left ventricle are presented in Table 1. Right and left total femoral TFD
(2.77 ± 0.38 and 2.70 ± 0.24, respectively) from animals with micro-
spheres injected in the left ventricle were not signiﬁcantly different (p
= 0.75). Right and left tibial TFD (1.11 ± 0.26 and 1.08 ± 0.34, respec-
tively) were also not different (p = 0.59). The coefﬁcient of variation
(CV) of TFDs among the ﬁve animals was 10.95% and 26.06% for the
femur and tibia, respectively. Partitioning of the tissue perfusion into
three segments along the length of the bone showed the proximal
femur received 27.30 ± 4.04%, the distal femur 51.34 ± 7.97%, and
the femoral diaphysis 21.36 ± 6.68% of total femoral perfusion (Fig.
3). The tibia partitioning showed proximal tibia received 68.77 ±
5.86%, the distal tibia 10.68 ± 4.18%, and the tibial diaphysis 20.55 ±
5.86% of total tibial perfusion. Bone segment masses are presented in
Supplementary Table 1.
Tail vein injection resulted in unacceptably low levels of tibia perfu-
sion (TFD) in the tibia from4 of the 5 animals (Table 2). Analyses of fem-
ora from these animals were not undertaken.
4. Discussion
The importance of bone blood ﬂow in skeletal health, and its role in
disease has been established through several preclinical experiments.
Although, the gold standard for bone blood ﬂow measurement has
been the injection of radioactive microspheres, ﬂuorescent micro-
spheres have been established as a safer and equally effective technique
for non-skeletal tissues (such as lung, kidney, and brain). Measures of
bone blood ﬂow using ﬂuorescent microspheres presents challenges
due to the difﬁculty of imaging throughmineralized tissue and the tech-
nical difﬁculty of current microsphere assays, especially in small ani-
mals. The current work extends the use of ﬂuorescent microspheres,
described in detail for mice (Serrat, 2009), to assess bone perfusion in
rats.
Although the use of ﬂuorescentmicrospheres has beenwell detailed
in mice (Serrat, 2009), some protocol adaptations were needed tomea-
sure ﬂuorescent microspheres in rat. A larger absolute number ofFig. 2.Microsphere standard curves displayed as bead quantity and ﬂmicrospheres was used based on the recommendation of approximate-
ly 5million spheres/kg of bodyweight used successfully inmice (Serrat,
2009). Due to larger volume of tissue in rat compared to mouse, larger
volumes of ethanolic KOHwere needed to degrade the tissue. Segments
of bone were placed in 15 mL of 10% ethanolic KOH (vs 8 mL of 3%
ethanolic KOH in mice). Also due to the larger tissue volume, a larger
vacuum ﬁltration apparatus was necessary to ﬁlter the degraded sam-
ples. Degraded samples were ﬁltered through 47 mm polyamide ﬁlters
(versus 25 mm ﬁlters used in mice).
Our results on tibia and femoral perfusion match closely with previ-
ous reports examining values across these two bones as well as region-
allywithin each bone. The ratio of femoral to tibial perfusion reported in
the current work matches the results of previous studies performed
using microspheres in rats (MacPherson and Tothill, 2012; Kapitola
and Zák, 1998) and dogs (Okubo et al., 1979). The percentage of tissue
perfusion to the different segments of the femur and tibia reported in
our work also match values using radioactive microspheres showing
highest ﬂow in distal femur and proximal tibia (Schoutens et al.,
1979). This congruence with previous work lends support to theuorescence. (A) Effects of storage conditions. (B) Effects of time.
Fig. 3. Tissue ﬂuorescent density (TFD) of segmented femur (A, C) and tibia (B, D). RPF, right proximal femur; LPF, left proximal femur; RFD, right femoral diaphysis; LFD, left femoral
diaphysis; RDF, right distal femur; LDF, left distal femur; RPT, right proximal tibia; LPT, left proximal tibia; RTD, right tibial diaphysis; LTD, left tibial diaphysis; RDT, right distal tibia;
LDT, left distal tibia. Data presented as means and standard deviations.
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perfusion in rats.
Many regional organ perfusion protocols usingmicrospheres require
technically challenging surgical techniques including catheter place-
ment into the left ventricle to injectmicrospheres, and another catheter
placement in the carotid artery or the tail artery to collect a reference
blood sample. These techniques are further complicated when per-
formed in rodents, given the smaller size of vessels. Because of potential
variability in several steps of the sphere administration process, it is
worthwhile to ﬁnd an alternative way to assure adequate spheres are
administered. The use of blood as a reference tissue has been used ex-
tensively, but other protocols have used organs as the reference tissue
(Serrat, 2009). The advantage of using an organ as a reference tissue is
it eliminates theneed for catheter placement in vesselswhile the animal
is alive. While this will work for interventions that are isolated (such as
limb cooling used in themouse protocol (Serrat, 2009)), our end-goal of
thiswork is to study skeletal perfusion in the context of systemic disease
which will likely affect blood ﬂow systemically (and potentially differ-
ently across skeletal sites).
In the current study, microspheres were injection into the left ven-
tricle after opening the chest cavity while the animal was under anes-
thesia as a terminal procedure. Variability in cardiac function before
the animal is euthanized due to invasion of the chest cavity was not
assessed in the present study and could account for variability among
animals. In an attempt to reduce this variability, injections were per-
formed in the tail vein for a subset of animals in order to allow the ani-
mal to maintain normal cardiac function to distribute the spheresTable 2
Tibia tissue ﬂuorescence density following cardiac versus tail vein microsphere injection.
Animal Cardiac injection Animal Tail injection
Right tibia Left tibia Right tibia Left tibia
1 1.51 1.37 6 1.04 1.34
2 1.13 1.44 7 0.04 0.02
3 0.81 0.87 8 0.03 0.01
4 1.12 0.63 9 0.02 0.01
5 0.96 1.10 10 0.03 0.02
Mean 1.11 1.08 0.23 0.28
Stdev 0.26 0.34 0.45 0.59
Tissue ﬂuorescence density (TFD) data presented as AU/g and scaled by 106.systemically. Although itwas assumed that sphereswould be entrapped
in the pulmonary capillaries, if enough microspheres passed through to
the arterial system, bone perfusion could be measured while also pre-
serving cardiac function. Our results clearly showed that microsphere
entrapment in bone was insufﬁcient for reliable measure and thus this
is not a viable method of administration.
In the present study, we have shown that the injection of ﬂuorescent
microspheres in the left ventricle of rats is an effective method for the
estimation of bone perfusion. However, there are a number of limita-
tions to this study. Due to the fact that we did not collect a blood sample
during injection, we are unable to calculate an estimated ﬂow rate to
bone. Although a ﬂow rate provides an easily interpretable value (mL/
min per tissue weight), it is worth noting that collection of reference
blood from the tail artery, as many do (McDonald et al., 1992;
Bloomﬁeld et al., 2002), likely underestimates the concentration of
spheres in organs since it is distal to a majority of the arterial tree in-
cluding highly vascularized tissue including the brain and kidneys. An-
other limitation to our study is the lack of hemodynamic stability
during the microsphere injection procedure and microsphere circula-
tion. The animals are anesthetized using isoﬂurane, which is known to
affect organ perfusion (Bernard et al., 1991) and cardiovascular dynam-
ics (Bernard et al., 1990). Finally, without the use of assisted ventilation,
this is a terminal procedure and does not allow for the serial injection of
microspheres for the evaluation of longitudinal change in skeletal perfu-
sion. This could be overcomeby administration of spheres via prolonged
or repeated catheterization if longitudinal measures are of interest.
Although the use of ﬂuorescent microspheres is emerging as an ac-
cepted alternative to radioactivemicrospheres as amethod for themea-
surement of blood ﬂow, and some papers have used the technique to
examine bone, there has yet to be a study to assess these techniques
in rats. The current work ﬁlls this void by showing the viability of injec-
tion and analysis of ﬂuorescent microspheres to assess regional bone
tissue perfusion in rats.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bonr.2017.04.004.References
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